Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
Annals of Thoracic and Cardiovascular Surgery · 2026 · 32 (1) · n/a
DOI: 10.5761/atcs.oa.26-00107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Ruihan Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Esophageal and Gastroenterological Surgery, Juntendo University, Tokyo, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Nivolumab, Neoadjuvant Therapy, Esophagectomy. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Esophageal and Gastroenterological Surgery, Juntendo University, Tokyo, Japan.
Zitieren
APA
Zeng, R., Mine, S., Nasu, M., Hashimoto, T., Makuuchi, R., Ozaki, A., Yoshimoto, Y., Watanabe, T., Takai, S., & Fukunaga, T. (2026). Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Annals of Thoracic and Cardiovascular Surgery, 32(1), n/a. https://doi.org/10.5761/atcs.oa.26-00107
Vancouver
Zeng R, Mine S, Nasu M, Hashimoto T, Makuuchi R, Ozaki A, et al. Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Annals of Thoracic and Cardiovascular Surgery. 2026;32(1):n/a. doi:10.5761/atcs.oa.26-00107
BibTeX
@article{Zeng2026,
author = {Zeng, Ruihan and Mine, Shinji and Nasu, Motomi and Hashimoto, Takashi and Makuuchi, Rie and Ozaki, Asako and Yoshimoto, Yutaro and Watanabe, Takehiro and Takai, Shotaro and Fukunaga, Tetsu},
title = {Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma},
journal = {Annals of Thoracic and Cardiovascular Surgery},
year = {2026},
volume = {32},
number = {1},
pages = {n/a},
doi = {10.5761/atcs.oa.26-00107}
}
EUVIMED